Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Minnesota for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Minnesota only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Minnesota (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ben Zhang (NPI 1366738098)

Field	Value
Entity Type	Individual
Organization	Ben Zhang
Address	675 E Nicollet Blvd Ste 100
City	Burnsville
State	MN
ZIP	55337
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	June 21, 2011

Payer Source	Total Paid
Medicare	$914.4K
Medicaid	$0

Key Findings

This provider’s billed Medicare revenue totals $914.4K while Medicaid shows none (no Medicaid billing on file), so the provider’s public claims footprint is effectively single‑payer Medicare rather than a mixed Medicare/Medicaid practice. Analysts should treat Medicare as the primary commercial data source for performance and utilization insights.

Revenue is highly concentrated in a very small set of drugs and services: the precomputed top three Medicare codes account for 77.5% of total Medicare revenue, led by J9271 ($593.4K, 67.3%), followed by 99214 ($53.3K, 6.0%) and Q5119 ($37K, 4.2%). This concentration implies that a single high‑cost drug dominates the practice’s reimbursement profile.

The code mix and counts indicate an infusion‑heavy hematology/oncology practice: J9271 (pembrolizumab) shows 13.8K claims and is the dominant revenue driver, and procedural chemotherapy administration codes such as 96413 (295 claims, $30.4K) and 96401 (186 claims, $11K) appear throughout the top codes. Supportive oncology agents are also present (J2506 pegfilgrastim: 396 claims, $30.5K), consistent with a clinic focused on systemic cancer therapy and supportive care.

Competitive standing for the top drug: J9271 ranks #771 of 1841 nationally (57th percentile; typical, unremarkable volume for this code), indicating the provider is a modest, not market‑leading, national participant in pembrolizumab administration despite it driving the majority of revenue. This suggests strong reliance on a commonly used immunotherapy rather than a niche or unusually large infusion program.

Office evaluation and management activity shows routine outpatient follow‑up volume: 99214 appears with 573 claims and $53.3K in revenue and ranks #38683 of 479517 nationally (92th percentile; typical, unremarkable volume for this code), suggesting steady chronic care and follow‑up visits consistent with longitudinal oncology management rather than episodic or rare consults.

There are several low‑percentile items in the mix that are comparatively uncommon for this provider: J1568 (immune globulin) ranks #372 of 381 (2th percentile) and J9217 (leuprolide acetate) ranks #3194 of 3683 (12th percentile), indicating these services are relatively infrequent in the provider’s billing compared with peers. These low ranks suggest the practice’s service line is concentrated on oncology infusions tied to cancer therapeutics rather than broader immunology or urology injections.

Operationally, the practice’s revenue profile shows much more dollar concentration in infused biologic/drug codes than in non‑drug office revenue: J9271 alone accounts for $593.4K while typical E/M codes such as 99214 and 99213 together represent a much smaller share of revenue ($53.3K and $2.9K respectively). For payers and network planning, this flags the provider as a high‑drug‑cost infusion site where drug acquisition, buy‑and‑bill arrangements, and specialty drug utilization will drive cost and contracting considerations.

The NPI tenure is long enough to indicate an established practice relationship: the NPI was enumerated 2011-06-21 (~15 years ago), which supports interpreting the observed billing mix as a sustained practice pattern rather than a short‑term or startup anomaly.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

54 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	13,800	$40	$593.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	570	$90	$53.3K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	1,680	$20	$37K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	400	$80	$30.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	300	$100	$30.4K
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	820	$30	$27.1K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	12,720	$1	$25.4K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	190	$60	$11K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	70	$130	$8.8K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	950	$10	$7.6K

Showing 1–10 of 54

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 54 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Minnesota Distribution

Ben Zhang — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Minnesota

Full comparison — all codes billed, vs. state median

54 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	3	70	7,200	$40	$323.3K
J1568	6	10	3,560	$30	$141.7K
J2506	7	20	290	$80	$34.3K
Q5119	4	30	1,380	$20	$29.5K
J0881	5	20	10,680	$1	$25.4K
J9217	51	80	80	$130	$17.1K
J0185	16	30	7,800	$1	$11.9K
96413	19	230	70	$100	$11.5K
83521	4	50	60	$20	$8.3K
99214	84	10,100	70	$80	$8.1K

Showing 1–10 of 54

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ben Zhang, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Holland Center	MN	Developmentally Disabled Services Day Training Agency	$0	$16.3M
Minnesota Oncology Hematology, PA	MN	Hematology & Oncology Physician	$0	$8.1M
Robert Delaune	MN	Hematology & Oncology Physician	$1.9M	$0
Vladimir Hugec	MN	Hematology & Oncology Physician	$1.8M	$0
Yang Liu	MN	Hematology & Oncology Physician	$1.4M	$0
David King	MN	Medical Oncology Physician	$1.3M	$0
Avina Singh	MN	Hematology & Oncology Physician	$971.9K	$0
Uzma Ali	MN	Hematology & Oncology Physician	$868.9K	$0
Samith Thomas Kochuparambil	MN	Hematology & Oncology Physician	$827.8K	$0
Ryan Funk	MN	Radiation Oncology Physician	$716.7K	$0

Nearby Providers

Other providers in the same ZIP code as Ben Zhang, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Lodges Company	MN	Assisted Living Facility	$0	$39.1M
Fairview Health Services	MN	General Acute Care Hospital	$0	$30M
Ind School District 191	MN	Local Education Agency (LEA)	$0	$13.1M
Mental Health Resources, Inc.	MN	Case Management Agency	$0	$12.8M
Community Drug & Alcohol Services Inc	MN	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$12M
Mercy Link, LLC	MN	Home Health Agency	$0	$9.9M
Valley Pain Relief And Wellness Center, PLLC	MN	Pain Medicine (Physical Medicine & Rehabilitation) Physician	$0	$9.3M
Professional Portable Radiologic Services, Inc.	MN	Portable X-ray and/or Other Portable Diagnostic Imaging Supplier	$1.1M	$6.2M
Augustana Emerald Care LLC	MN	Assisted Living Facility	$0	$5.8M
Fairview Clinics	MN	Primary Care Clinic/Center	$0	$4.7M

Ben Zhang — Billing Profile & Reimbursement Data

Sign up for Ben Zhang — Billing Profile & Reimbursement Data policy alerts

Ben Zhang — Billing Profile & Reimbursement Data

Sign up for Ben Zhang — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References